Thank you very much, Chair.
I'll be splitting my time with my colleague Mr. McGuinty.
In today's opening remarks, the situation we're dealing with was described as “the sick looking after the sick”. This is an issue of life and death. And one key indicator used to indicate why this issue is life and death is that anything less than 50%, in terms of the isotope supply, makes it a situation of life and death because you're pitting one patient against the other, ultimately, and making those tough choices when you prioritize the needs of the patients and the diagnoses.
Where are we now, in terms of the isotope supply? How do we measure that? How do we track that? Where do we stand? Are we at the 50% threshold? Are we below that threshold? Are we above that?